We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current TELO market cap is 162.85M. The company's latest EPS is USD -0.4415 and P/E is -12.46.
| Quarter End | Dec 2023 | Mar 2024 | |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | |
| Operating Income | -1.08M | -1.92M | |
| Net Income | -9.33M | -6.26M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -138k | -854k | -3.94M |
| Net Income | -138k | -854k | -13.07M |
| Quarter End | Dec 2023 | Mar 2024 | |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.77M | 3.5M | |
| Total Liabilities | 1.34M | 486k | |
| Total Equity | 3.44M | 3.02M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 0 | 49k | 4.77M |
| Total Liabilities | 138k | 986k | 1.34M |
| Total Equity | -138k | -937k | 3.44M |
| Market Cap | 162.85M |
| Price to Earnings Ratio | -12.46 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 47.37 |
| Dividend Yield | - |
| Shares Outstanding | 29.61M |
| Average Volume (1 week) | 46.37k |
| Average Volume (1 Month) | 36.1k |
| 52 Week Change | -21.43% |
| 52 Week High | 20.72 |
| 52 Week Low | 4.76 |
| Spread (Intraday) | 1.29 (20.48%) |
| Company Name | Telomir Pharmaceuticals Inc |
| Address |
900 west platt street, suite 200 tampa, florida 33606 |
| Website | https://www.telomirpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
